MHR
Matthew Hamilton Rosenberg’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $519K | Buy |
666
+24
| +4% | +$18.7K | 0.12% | 81 |
|
|
2025
Q1 | $530K | Sell |
642
-50
| -7% | -$41.3K | 0.13% | 73 |
|
|
2024
Q4 | $534K | Buy |
692
+18
| +3% | +$13.9K | 0.14% | 70 |
|
|
2024
Q3 | $597K | Buy |
674
+20
| +3% | +$17.7K | 0.16% | 67 |
|
|
2024
Q2 | $598K | Sell |
654
-13
| -2% | -$11.9K | 0.18% | 61 |
|
|
2024
Q1 | $507K | Buy |
667
+28
| +4% | +$21.3K | 0.15% | 70 |
|
|
2023
Q4 | $373K | Buy |
639
+11
| +2% | +$6.42K | 0.11% | 93 |
|
|
2023
Q3 | $337K | Hold |
628
| – | – | 0.11% | 94 |
|
|
2023
Q2 | $295K | Sell |
628
-165
| -21% | -$77.4K | 0.1% | 114 |
|
|
2023
Q1 | $272K | Hold |
793
| – | – | 0.09% | 140 |
|
|
2022
Q4 | $290K | Hold |
793
| – | – | 0.1% | 133 |
|
|
2022
Q3 | $256K | Buy |
793
+9
| +1% | +$2.91K | 0.1% | 121 |
|
|
2022
Q2 | $255K | Hold |
784
| – | – | 0.1% | 127 |
|
|
2022
Q1 | $225K | Buy |
784
+44
| +6% | +$12.6K | 0.08% | 168 |
|
|
2021
Q4 | $204K | Hold |
740
| – | – | 0.07% | 179 |
|
|
2021
Q3 | $171K | Buy |
740
+188
| +34% | +$43.4K | 0.07% | 188 |
|
|
2021
Q2 | $127K | Hold |
552
| – | – | 0.07% | 219 |
|
|
2021
Q1 | $103K | Buy |
552
+49
| +10% | +$9.14K | 0.06% | 244 |
|
|
2020
Q4 | $85K | Buy |
503
+70
| +16% | +$11.8K | 0.05% | 250 |
|
|
2020
Q3 | $64K | Hold |
433
| – | – | 0.05% | 272 |
|
|
2020
Q2 | $71K | Buy |
433
+90
| +26% | +$14.8K | 0.06% | 250 |
|
|
2020
Q1 | $48K | Buy |
+343
| New | +$48K | 0.05% | 261 |
|